• Sotera Health stockholders affiliated with Warburg Pincus, GTCR sold 31,838,253 common shares in a secondary offering priced at USD 15.17 per share.
• Goldman Sachs acted as underwriter; shares were sold to underwriter on May 13, 2026.
• Sotera Health did not issue stock, will not receive proceeds; executive officers did not participate.
• Sponsors exited entire common stock position, triggering termination of stockholders agreement; special governance rights ended, including director designation rights.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sotera Health Co. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-221630), on May 13, 2026, and is solely responsible for the information contained therein.